Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1956 1
1961 2
1962 3
1963 1
1964 9
1965 1
1966 2
1967 5
1968 7
1969 8
1970 6
1971 9
1972 13
1973 6
1974 9
1975 6
1976 11
1977 8
1978 14
1979 12
1980 22
1981 16
1982 20
1983 31
1984 27
1985 38
1986 43
1987 46
1988 48
1989 63
1990 64
1991 50
1992 74
1993 48
1994 67
1995 63
1996 77
1997 85
1998 92
1999 87
2000 84
2001 73
2002 58
2003 70
2004 98
2005 99
2006 106
2007 91
2008 92
2009 88
2010 99
2011 121
2012 119
2013 149
2014 148
2015 125
2016 138
2017 148
2018 148
2019 134
2020 173
2021 207
2022 234
2023 193
2024 155
2025 155

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,179 results

Results by year

Filters applied: . Clear all
Page 1
Cefepime-induced neurotoxicity: systematic review.
Maan G, Keitoku K, Kimura N, Sawada H, Pham A, Yeo J, Hagiya H, Nishimura Y. Maan G, et al. Among authors: nishimura y. J Antimicrob Chemother. 2022 Oct 28;77(11):2908-2921. doi: 10.1093/jac/dkac271. J Antimicrob Chemother. 2022. PMID: 35971666
Eosinophilic myocarditis: systematic review.
Techasatian W, Gozun M, Vo K, Yokoyama J, Nagamine T, Shah P, Vu K, Zhang J, Nishimura Y. Techasatian W, et al. Among authors: nishimura y. Heart. 2024 Apr 25;110(10):687-693. doi: 10.1136/heartjnl-2023-323225. Heart. 2024. PMID: 37963727
[Preface].
Nishimura Y, Tomita S. Nishimura Y, et al. Nihon Yakurigaku Zasshi. 2023;158(6):427. doi: 10.1254/fpj.23070. Nihon Yakurigaku Zasshi. 2023. PMID: 37914315 Japanese. No abstract available.
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor.
Tanada M, Tamiya M, Matsuo A, Chiyoda A, Takano K, Ito T, Irie M, Kotake T, Takeyama R, Kawada H, Hayashi R, Ishikawa S, Nomura K, Furuichi N, Morita Y, Kage M, Hashimoto S, Nii K, Sase H, Ohara K, Ohta A, Kuramoto S, Nishimura Y, Iikura H, Shiraishi T. Tanada M, et al. Among authors: nishimura y. J Am Chem Soc. 2023 Aug 2;145(30):16610-16620. doi: 10.1021/jacs.3c03886. Epub 2023 Jul 18. J Am Chem Soc. 2023. PMID: 37463267
Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD.
Mae SI, Hattanda F, Morita H, Nozaki A, Katagiri N, Ogawa H, Teranaka K, Nishimura Y, Kudoh A, Yamanaka S, Matsuse K, Ryosaka M, Watanabe A, Soga T, Nishio S, Osafune K. Mae SI, et al. Among authors: nishimura y. Cell Rep. 2023 Dec 26;42(12):113431. doi: 10.1016/j.celrep.2023.113431. Epub 2023 Nov 30. Cell Rep. 2023. PMID: 38039961 Free article.
Treatment with epcoritamab in 10 patients in real-world clinical practice.
Sekiguchi Y, Tsutsumi H, Kudo M, Maseki N, Iizaki Y, Kawamura M, Kobayashi K, Nishimura Y, Kanda H, Takei D, Abe T, Hanai M, Nakayama T, Shimano Y, Kobayashi H. Sekiguchi Y, et al. Among authors: nishimura y. J Clin Exp Hematop. 2024 Dec 25;64(4):332-334. doi: 10.3960/jslrt.24054. Epub 2024 Nov 28. J Clin Exp Hematop. 2024. PMID: 39603633 Free PMC article. No abstract available.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: nishimura y. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets.
Ohta A, Tanada M, Shinohara S, Morita Y, Nakano K, Yamagishi Y, Takano R, Kariyuki S, Iida T, Matsuo A, Ozeki K, Emura T, Sakurai Y, Takano K, Higashida A, Kojima M, Muraoka T, Takeyama R, Kato T, Kimura K, Ogawa K, Ohara K, Tanaka S, Kikuchi Y, Hisada N, Hayashi R, Nishimura Y, Nomura K, Tachibana T, Irie M, Kawada H, Torizawa T, Murao N, Kotake T, Tanaka M, Ishikawa S, Miyake T, Tamiya M, Arai M, Chiyoda A, Akai S, Sase H, Kuramoto S, Ito T, Shiraishi T, Kojima T, Iikura H. Ohta A, et al. Among authors: nishimura y. J Am Chem Soc. 2023 Nov 8;145(44):24035-24051. doi: 10.1021/jacs.3c07145. Epub 2023 Oct 24. J Am Chem Soc. 2023. PMID: 37874670
Non-Clonal Lymphoproliferative Diseases.
Dirnhofer S, Nishimura Y, Dispenzieri A. Dirnhofer S, et al. Among authors: nishimura y. Hematol Oncol. 2025 Jun;43 Suppl 2:e70065. doi: 10.1002/hon.70065. Hematol Oncol. 2025. PMID: 40517541 Review.
4,179 results